๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Activity of the multitargeted antifolate LY231514 in the human tumor cloning assay

โœ Scribed by Carolyn D. Britten; Elzbieta Izbicka; Susan Hilsenbeck; Richard Lawrence; Karen Davidson; Caeser Cerna; Lionel Gomez; Eric K. Rowinsky; Steven Weitman; Daniel D. Von Hoff

Publisher
Springer
Year
1999
Tongue
English
Weight
110 KB
Volume
44
Category
Article
ISSN
0344-5704

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Activity of multitargeted antifolate (pe
Activity of multitargeted antifolate (pemetrexed disodium, LY231514) in patients with advanced colorectal carcinoma : Results from a Phase II study
โœ William John; Joel Picus; Charles D. Blanke; Jeffery W. Clark; Lawrence N. Schul ๐Ÿ“‚ Article ๐Ÿ“… 2000 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 80 KB ๐Ÿ‘ 1 views

## BACKGROUND. The aim of this study was to confirm the activity and assess the safety profile of multitargeted antifolate (MTA) for patients with metastatic colorectal adenocarcinoma. ## METHODS. Forty-six patients were enrolled in the study, 35 with colon and 11 with rectal carcinoma. Adjuvant

Antitumor activity of vinzolidine in the
Antitumor activity of vinzolidine in the human tumor clonogenic assay and comparison with vinblastine
โœ Bonnie J. Takasugi; Sydney E. Salmon; Robert L. Nelson; Laurie Young; Rosa M. Li ๐Ÿ“‚ Article ๐Ÿ“… 1984 ๐Ÿ› Springer US ๐ŸŒ English โš– 390 KB

Vinzolidine (VZL), a semisynthetic vinblastine (VLB) derivative, was tested against a variety of solid tumors in the human tumor clonogenic assay (HTCA). The emphasis was on continuous drug exposure because of the schedule-dependency of the vincas and long half-life of VZL. Of tumor types with more